Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
2,303,245
-
Share change
-
+317,379
-
Total reported value
-
$106,302,032
-
Put/Call ratio
-
193%
-
Price per share
-
$46.15
-
Number of holders
-
75
-
Value change
-
+$14,606,845
-
Number of buys
-
33
-
Number of sells
-
27
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q4 2021
As of 31 Dec 2021,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,303,245 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, LPL Financial LLC, ROYAL BANK OF CANADA, CENTAURUS FINANCIAL, INC., MAI Capital Management, SUSQUEHANNA INTERNATIONAL GROUP, LLP, PNC Financial Services Group, Inc., and FIRST CITIZENS BANK & TRUST CO.
This page lists
75
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.